article thumbnail

Sanofi to expand immunology offerings with Blueprint Medicines

Pharmaceutical Technology

Sanofi has signed an agreement to acquire US-based Blueprint Medicines to bolster its immunology pipeline with rare disease treatments.

Medicine 162
article thumbnail

A startup banks $66M to pursue ‘inclusive precision medicine’

Bio Pharma Dive

With backers such as Regeneron’s venture arm, Actio Biosciences is working on medicines that counter a wide range of disease-causing genetic mutations in conditions like epilepsy and Charcot-Marie-Tooth disease.

Medicine 144
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Using artificial intelligence to enhance regenerative medicine

Pharmaceutical Technology

As the field of regenerative medicine continues to advance, the incorporation of AI is playing a transformative role in the pharmaceutical industry.

Medicine 277
article thumbnail

Orionis and Genentech link on oncology small-molecule glue medicines

Pharmaceutical Technology

Orionis Biosciences has announced a multi-year partnership with Roches Genentech for small-molecule monovalent glue medicine.

Medicine 130
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine.

article thumbnail

A bespoke CRISPR therapy suggests a blueprint for treating ‘N-of-1’ diseases

Bio Pharma Dive

A gene editing drug custom-made for a critically ill baby showed that, for some ultra-rare diseases, it’s possible to design and test a new CRISPR medicine in just a few months.

article thumbnail

FDA approves twice-yearly shot of Gilead drug for HIV prevention

Bio Pharma Dive

The clearance ushers in a closely-watched launch for Gilead, which aims to show a long-acting injection can upend a market dominated by oral medicines.

article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research.